Latest News

News

FDA approves lenvatinib for HCC

Lenvatinib was found noninferior but not statistically superior to sorafenib for overall survival in a trial of 954 patients.

From the Journals

Feds aim to streamline gene therapy oversight

“It seems reasonable to envision a day when gene therapy will be a mainstay of treatment for many diseases,” Dr. Collins and Dr. Gottlieb wrote....

Pages